Key role for mast cells in nonatopic asthma

Area of Science:

• Immunology
• Pulmonology
• Allergy

Background:

• Mechanisms of nonatopic asthma remain unclear.
• The specific role of mast cells in nonatopic asthma pathogenesis is not well-defined.
• A murine model using dinitrofluorobenzene (DNFB) sensitization and intra-airway challenge with dinitrobenzene sulfonic acid (DNS) simulates nonatopic asthma.

Purpose of the Study:

• To investigate the critical role of mast cells in the development of nonatopic asthma using a established murine model.
• To analyze mast cell activation during the early phase of the pulmonary hypersensitivity response.
• To assess the impact of mast cell deficiency on both early and late-phase responses in this asthma model.

Main Methods:

• Utilized a mouse model involving skin sensitization with DNFB followed by intra-airway DNS challenge.
• Monitored mast cell activation in BALB/c mice and mast cell-deficient W/W(v) and Sl/Sl(d) mice.
• Compared responses in normal, mast cell-deficient, and reconstituted mice to evaluate mast cell function.

Main Results:

• Early-phase mast cell activation occurred within 30 minutes post-challenge in sensitized normal mice, but not in mast cell-deficient mice.
• Acute bronchoconstriction and increased vascular permeability were associated with early-phase mast cell activation.
• Mast cell-deficient mice failed to exhibit hypersensitivity responses, including tracheal hyperreactivity and late-phase inflammation, unlike normal and reconstituted mice.

Conclusions:

• Mast cells play a pivotal role in initiating and regulating pulmonary hypersensitivity reactions characteristic of nonatopic asthma.
• The absence of mast cells abrogates key features of the asthma phenotype in this murine model.
• Targeting mast cell activity may represent a therapeutic strategy for nonatopic asthma.